Trial Profile
A Randomized Phase II Trial Of ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2007
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Carboplatin; Cisplatin
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 03 Sep 2005 New trial record.